#zydus-lifesciences
Zydus Lifesciences to pursue acquisitions in specialty, rare diseases
Zydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology business in the US. The company reported robust financial growth for the fourth quarter of 2025-26. Zydus also announced a …
Zydus Lifesciences beats estimates, sees high-teens growth in FY27
For FY26, its revenue from operations stood at ₹27,148.4 crore, up 17% on-year, and adjusted net profit grew 15% to ₹5,456.4 crore.
Zydus Lifesciences Q4 profit rises 8.7% to ₹1,272 crore; announces ₹1,100 crore buyback
Zydus Lifesciences Limited reported an 8.7% year-on-year increase in consolidated net profit that stood at ₹1,272 crore for the quarter ended March 2026, impacted by a one-time expense related to the Mirabegron litigation settlement.
BREAKINGGuardant Health to launch blood-based cancer test in India with Zydus Lifesciences
Guardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, developed with Zydus Lifesciences, aims to identify various cancers like lung, breast, and prostate. The initiative targets India's hi…